Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer: an Open-label, Single-arm, Multicentre, Phase 2 Study

NCT06990061 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

NETWORK

Sponsor class

Conditions

Non-Muscle Invasive Bladder Cancer

Interventions

RADIATION: Radiation therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC